Crossmark

A Real-World Evaluation of Racial Disparities in the Receipt of Cancer Treatments and Anthracycline-Based Chemotherapies in Early-Stage Breast Cancer Patients

Crossref DOI link: https://doi.org/10.1007/s40615-025-02801-2

Published Online: 2026-01-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ho, Katherine L.

Jin, Mu

Visvanathan, Kala

Connor, Avonne E. https://orcid.org/0000-0002-7453-3892
Funding

Funding for this research was provided by:

American Cancer Society (RWIA-22-178-01-RWIA)
License Information

Text and Data Mining valid from 2026-01-16

Version of Record valid from 2026-01-16
More Information

Article History

Received: 8 August 2025

Revised: 2 December 2025

Accepted: 5 December 2025

First Online: 16 January 2026

Competing Interests

: The authors have no relevant financial or non-financial interests to disclose.

Document is current

Any future updates will be listed below